(02) 9399 1024
Paulo is a PhD Candidate at School of Public Health and Community Medicine (UNSW) and Neuroscience Research Australia (NeuRA) who is interested in ageing process and Parkinson’s disease population. Moreover, Paulo has been investigating clinical, motor features and risk of falling in people with Parkinson’s disease. Currently, Paulo has been working on fNIRS analysis to understand the brain activity when older people and people with Parkinson’s disease are performing balance tasks. Also, Paulo has been working on a Randomized controlled trial to reduce the risk of falling in people with Parkinson’s disease.
A randomised controlled trial to reduce the risk of falling in people with Parkinson’s disease.
: +612 9399 1124
DINAZ PAREKH Research Assistant : firstname.lastname@example.org
JESSICA TURNER Research Assistant
JOANNE LO Research Assistant
: 9399 1209
DR YOSHIRO OKUBO Postdoctoral Researcher : email@example.com
MAYNA RATANAPONGLEKA Research Assistant
People with the PD PIGD subtype exhibit impaired gait stability that is not improved and frequently worsened by levodopa. New non-pharmaceutical approaches, technological (e.g. cueing) or exercise-based (e.g. balance training) are required to improve or compensate for mediolateral gait instability in this subtype and ultimately prevent falls.
Impaired gait adaptability is associated with high risk of falls in older adults. Reduced executive function, increased concern about falling and weaker quadriceps strength contribute significantly to this relationship. Training gait adaptability directly, as well as addressing the above mediators through cognitive, behavioural and physical training may maximise fall prevention efficacy.
To describe technical details of a custom-made vibratory system (RCVibro System), as well as to determine its reliability and functionality. We conclude that RCVibro System is a highly reliable system. The results demonstrate the potential usage of RCVibro System in clinical and research settings. Further investigation is needed in people with motor and neurological disorders.